Cargando…
Separation of Isomeric Tau Phosphopeptides from Alzheimer’s Disease Brain by Cyclic Ion Mobility Mass Spectrometry
[Image: see text] Alzheimer’s disease (AD) is a neurodegenerative disorder of increasing concern. It belongs to diseases termed tauopathies which are characterized by inclusions of abnormally hyperphosphorylated and truncated forms of the protein tau. Studies of tauopathies often focus on detection...
Autores principales: | Kováč, Andrej, Majerová, Petra, Nytka, Marianna, Cechová, Monika Zajacová, Bednář, Petr, Hájek, Roman, Cooper-Shepherd, Dale A., Muck, Alexander, Lemr, Karel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017020/ https://www.ncbi.nlm.nih.gov/pubmed/36706338 http://dx.doi.org/10.1021/jasms.2c00289 |
Ejemplares similares
-
Tau Protein and Its Role in Blood–Brain Barrier Dysfunction
por: Michalicova, Alena, et al.
Publicado: (2020) -
Identification of a Major Phosphopeptide in Human Tristetraprolin by Phosphopeptide Mapping and Mass Spectrometry
por: Cao, Heping, et al.
Publicado: (2014) -
High‐resolution ion mobility spectrometry–mass spectrometry for isomeric separation of prostanoids after Girard's reagent T derivatization
por: Lamont, Lieke, et al.
Publicado: (2022) -
Phosphopeptide Fragmentation and Site Localization
by Mass Spectrometry: An Update
por: Potel, Clement M., et al.
Publicado: (2018) -
Multimodal Tandem Mass Spectrometry Techniques for
the Analysis of Phosphopeptides
por: Paris, Johanna, et al.
Publicado: (2022)